Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $554 | 35 days | 35 days | |
| 5 mg | Inquiry | 35 days | 35 days | |
| 10 mg | Preferential | 35 days | 35 days |
| Description | Human IgG1 kappa-Deruxtecan, ADC Control (DAR 8) is an isotype control antibody-drug conjugate (ADC) that does not target a specific antigen, conjugated with approximately 8 Deruxtecan payload molecules via a cleavable linker. As a negative control, Human IgG1 kappa-Deruxtecan, ADC Control (DAR 8) is primarily used to distinguish target-specific effects from non-specific effects in ADC experiments. |
| Reactivity | Human |
| Application | Functional assay |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Deruxtecan |
| Isotype | Human IgG1 kappa |
| Storage | Store at low temperature, -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.